iShares S&P Global Healthcare Sector Index Fund (IXJ)
- Global Equity | Health/Biotechnology Funds
- Loading...
Best Fit Health/Biotechnology Funds ETFs
U.S. News evaluated 29 Health/Biotechnology Funds ETFs and 14 make our Best Fit list. Our list highlights the best passively managed funds for long-term investors. Rankings are assigned based on comparisons with Best Fit funds in this category.
| Best Fit Scorecard | |
|---|---|
| Costs | Good |
| Tracking Error | Good |
| Bid/Ask Ratio | Good |
| Holdings Diversity | Good |
Fund Description
The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the S&P Global 1200 Healthcare Sector IndexTM. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index measures the performance of companies that Standard & Poor's Financial Services LLC, a subsidiary of The McGraw-Hill Companies ("S&P") deems to be a part of the healthcare sector of the economy and that S&P believes are important to global markets. The fund is non-diversified.
Fund Snapshot Updated 05.20.2013
| Previous Close | $77.82 | Expense Ratio | 0.48% |
| YTD Return | 20.4% | Avg. 30-Day Volume | 72,632 |
| 1-Year Return | 35.9% | Market Cap | Loading... |
| Bid | $77.70 | Shares Outstanding | 10,750,000 |
| Ask | $77.72 | Dividends | $1.47 |
| Top 10 Holdings | |
|---|---|
| Johnson & Johnson (JNJ) | 9.53% |
| Pfizer Inc (PFE) | 7.99% |
| Merck & Co Inc New (MRK) | 5.29% |
| Sanofi (E:SAN) | 5.04% |
| Glaxosmithkline (E:GSK) | 4.98% |
| Bayer Ag (E:BAYN) | 3.46% |
| Gilead Sciences Inc (GILD) | 3.28% |
| Amgen Inc (AMGN) | 2.96% |
| Abbvie Inc (ABBV) | 2.83% |
| Bristol Myers Squibb Co (BMY) | 2.77% |
| % of Total Holdings | 48.10% |
